Breaking News Instant updates and real-time market news.

TSLA

Tesla

$256.42

-2.28 (-0.88%)

09:56
04/25/19
04/25
09:56
04/25/19
09:56

Tesla may be entering era of uncertainty, says Cowen

Cowen analyst Jeffrey Osborne says Tesla appears to be entering into an era of uncertainty as a period of normalized demand approaches after enjoying the last 18-24 months of pent up demand for the Model 3 from the deposit list. The analyst sees lower prices as largely indicative of a demand fishing expedition. Even as Tesla reiterated guidance, Osborne believes the company has some of the lowest forward-looking visibility in recent memory. He reiterates an Underperform rating and a $160 price target on the shares.

TSLA Tesla
$256.42

-2.28 (-0.88%)

04/25/19
04/25/19
DOWNGRADE
Target $275

Neutral
Tesla downgraded to Neutral at Wedbush on 'loss of confidence in story'
As previously reported, Wedbush analyst Daniel Ives downgraded Tesla to Neutral from Outperform as the demand story is quickly changing and the company has "unfortunately not adjusted to an evolving EV landscape." The analyst views this quarter as "one of top debacles" he has ever seen while "Musk & Co. in an episode out of the Twilight Zone act as if demand and profitability will magically return to the Tesla story." Ultimately, Ives believes the company's guidance is aggressive and management/board is not taking aggressive enough cost cutting actions and shutting down future endeavors to preserve capital and give a sustained path to profitability for the Street. The analyst also lowered his price target on the shares to $275 from $365 to reflect his reduced numbers for the coming years and his loss of confidence in the story.
04/25/19
BOFA
04/25/19
NO CHANGE
Target $225
BOFA
Underperform
BofA says Tesla seems 'amenable' to capital raise after uglier than expected Q1
BofA Merrill Lynch analyst John Murphy said Tesla's "uglier than expected" Q1 results were largely due on an operating basis to weaker deliveries, lower pricing, and lighter gross margins and he revised his estimates to be relatively consistent with the company's outlook and commentary, though he keeps an Underperform rating and $225 price target on the shares. Murphy also said he sees an earnings/cash inflection in the second half as "somewhat questionable." He believes that Elon Musk now "appears amenable" to a capital raise, quoting the CEO as having said "At this point, I do think there is some merit to raising capital." Murphy noted that he does not expect Tesla to turn the corner on free cash flow until after 2020.
04/25/19
JMPS
04/25/19
NO CHANGE
Target $369
JMPS
Outperform
Tesla U.S. demand should recover over course of year, says JMP Securities
JMP Securities analyst Joseph Osha said Tesla's Q1 results were weak, but not more than he expected, and noted that its Q2 outlook was ahead of his previous estimates. The analyst, who thinks following the report that it is "clear that U.S. demand should recover over the course of 2019," believes the company can make money and is an attractive investment if Tesla can hit its volume targets. He lowered his price target on Tesla shares to $369 from $374 but maintains an Outperform rating on the stock.
04/25/19
JEFF
04/25/19
NO CHANGE
Target $400
JEFF
Buy
Jefferies still sees 'path to sustained profitability' for Tesla
Jefferies analyst Philippe Houchois says that beyond last night's headline miss and "ongoing stress," he saw "enough positive surprises from auto gross margin resilience, cash earnings and gross liquidity to argue the shares have sufficiently re-priced." The analyst, who admits his Tesla call is "hard to live with at times," still sees value in the company's electric vehicle/connectivity technology and experimentation. He remains confident "there is a path to sustained profitability." Houchois keeps a Buy rating on Tesla with a $400 price target.

TODAY'S FREE FLY STORIES

MU

Micron

$32.71

-0.47 (-1.42%)

07:59
06/26/19
06/26
07:59
06/26/19
07:59
Upgrade
Micron rating change  »

Micron upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

CRCM

Care.com

$14.13

0.21 (1.51%)

, BBY

Best Buy

$66.42

-1.02 (-1.51%)

07:58
06/26/19
06/26
07:58
06/26/19
07:58
Downgrade
Care.com, Best Buy rating change  »

Care.com downgraded to…

CRCM

Care.com

$14.13

0.21 (1.51%)

BBY

Best Buy

$66.42

-1.02 (-1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Kinder Morgan rating change  »

Kinder Morgan downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

GEL

Genesis Energy

$21.59

-0.38 (-1.73%)

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Genesis Energy rating change  »

Genesis Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$26.80

-0.36 (-1.33%)

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Upgrade
Williams rating change  »

Williams upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$39.60

-0.49 (-1.22%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Hot Stocks
Acceleron completes target enrollment in PULSAR Phase 2 trial of sotatercept »

Acceleron Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 04

    Apr

KSHB

KushCo Holdings

$0.00

(0.00%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Initiation
KushCo Holdings initiated  »

Benchmark starts KushCo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

AYX

Alteryx

$104.20

-2 (-1.88%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSN

Parsons

$36.77

-0.045 (-0.12%)

07:51
06/26/19
06/26
07:51
06/26/19
07:51
Downgrade
Parsons rating change  »

Parsons downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$37.51

-0.625 (-1.64%)

07:48
06/26/19
06/26
07:48
06/26/19
07:48
Upgrade
Energizer rating change  »

Energizer upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$156.00

-4.88 (-3.03%)

, WMT

Walmart

$110.72

-0.53 (-0.48%)

07:48
06/26/19
06/26
07:48
06/26/19
07:48
Recommendations
FedEx, Walmart, Target, Amazon.com analyst commentary  »

FedEx price target…

FDX

FedEx

$156.00

-4.88 (-3.03%)

WMT

Walmart

$110.72

-0.53 (-0.48%)

TGT

Target

$85.70

-1.03 (-1.19%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 30

    Jul

  • 31

    Jul

  • 15

    Aug

  • 21

    Aug

  • 17

    Sep

  • 13

    Nov

07:45
06/26/19
06/26
07:45
06/26/19
07:45
General news
U.S. MBA reported mortgage applications bounced 1.3% »

U.S. MBA reported…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

, FVRR

Fiverr

$29.00

-0.2 (-0.68%)

07:44
06/26/19
06/26
07:44
06/26/19
07:44
Upgrade
Upwork, Fiverr rating change  »

Upwork upgraded to Buy…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

FVRR

Fiverr

$29.00

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINX

Linx S.A.

$0.00

(0.00%)

07:41
06/26/19
06/26
07:41
06/26/19
07:41
Syndicate
Linx S.A. 32.8M share IPO priced at $9.40 »

We are told the official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:40
06/26/19
06/26
07:40
06/26/19
07:40
General news
Treasury Market Outlook: Treasury yields jumped higher »

Treasury Market Outlook:…

BBRX

Braeburn Pharmaceuticals

$0.00

(0.00%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Braeburn Pharmaceuticals initiated  »

Braeburn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$90.27

-0.53 (-0.58%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Upgrade
Fiserv rating change at Northcoast »

Fiserv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVSI

Envision Solar

$5.11

-0.22 (-4.13%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Envision Solar initiated at Maxim »

Envision Solar initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$1.66

-0.05 (-2.93%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Initiation
Kadmon initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$57.44

-0.58 (-1.00%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Hot Stocks
Novocure announces publication of IQWiG rapid report for Optune »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTR

CapStar Financial

$15.01

0.05 (0.33%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Downgrade
CapStar Financial rating change at Sandler ONeill »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCRX

Pacira

$43.53

0.39 (0.90%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Hot Stocks
Pacira says results show EXPAREL associated with 'significantly less' opioid use »

Pacira BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODT

Odonate Therapeutics

$28.14

-0.29 (-1.02%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Syndicate
Odonate Therapeutics 4.75M share Spot Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jun

X

U.S. Steel

$14.93

0.48 (3.32%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.